The Gensol Crisis: A Cautionary Tale for Investors
Recent Stories
Next →
The Gensol Crisis: A Cautionary Tale for Investors
The Gensol–BluSmart saga is a crash course in what not to ignore as a retail investor. Read here to know more.
Lipstick, Lattes & Loose Change: The Economy’s Strangest Early Warning System?
Unusual signals—from lipstick to lattes—offering a satirical take on how the economy shows up in everyday behavior.
India-U.S. Trade at a Crossroads: What Rising U.S. Tariffs Mean for Indian Exports
This article decodes the math behind Washington’s tariff strategy, and evaluates how different Indian sectors may be impacted.
US Tariffs Rattle Global Markets, Strain Economies
India Hit by 26% US Tariff; Markets Slide as Global Trade Tensions Escalate.
India-U.S. Trade Surplus Under Fire: Pharma Sector in the Crosshairs
The U.S. is targeting India’s trade surplus with new tariffs. The high-value pharmaceutical sector now risks major disruption.
Decoding the Disconnect: Why Low-Growth Stocks Are Trading at High Multiples
Our latest data shows a surprising twist — many low-growth companies in Q4 are trading at higher valuations than their faster-growing peers, catching the market’s attention.